The next phase of the obesity drug race
US$ 24.62
semaglutide market size Size, Share Obesity GLP-1 Market
Description
Adults with a BMI of 27 or above who also have at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol
Both approaches act early in the chain
Do it with purpose, mixing only what you need for the next 2-4 weeks of your study
Yes, GLP-1s are considered safe to take by the FDA
